Omalizumab discontinuation in children with severe allergic asthma: An observational real-life study

Allergy. 2019 May;74(5):999-1003. doi: 10.1111/all.13678. Epub 2019 Jan 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Asthmatic Agents / adverse effects
  • Anti-Asthmatic Agents / chemistry
  • Anti-Asthmatic Agents / therapeutic use*
  • Asthma / diagnosis
  • Asthma / drug therapy*
  • Child
  • Disease Management
  • Humans
  • Omalizumab / adverse effects
  • Omalizumab / chemistry
  • Omalizumab / therapeutic use*
  • Respiratory Function Tests
  • Severity of Illness Index

Substances

  • Anti-Asthmatic Agents
  • Omalizumab